Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases, Viral

Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.

6,138 public trials 362 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases, Viral trial results

Completed

Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults

NCT03945981

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Palm Springs, California, United States
  • GSK Investigational Site Ft. Pierce, Florida, United States
View all 16 locations
View Trial Details
Completed

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

NCT00592124

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Microbicide CRS Birmingham, Alabama, United States
  • Bronx- Lebanon Hospital Center Clinical Research Site (BLHC CRS) The Bronx, New York, United States
  • Case CRS Cleveland, Ohio, United States
  • Pitt CRS Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults

NCT02178800

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Bridge HIV CRS San Francisco, California, United States
  • George Washington Univ. CRS Washington D.C., District of Columbia, United States
  • Chapel Hill CRS Chapel Hill, North Carolina, United States
View Trial Details
Completed

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
  • Seattle Vaccine and Prevention CRS Seattle, Washington, United States
View Trial Details
Completed

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

NCT00007332

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Dept. of Public Health, San Francisco Gen. Hosp. San Francisco, California, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
View all 17 locations
View Trial Details
Completed

Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

NCT00413725

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Soweto HVTN CRS Johannesburg, Gauteng, South Africa
  • MedCRU CRS Pretoria, Gauteng, South Africa
  • eThekwini CRS Durban, KwaZulu-Natal, South Africa
  • Emavundleni CRS Cape Town, Western Cape, South Africa
View Trial Details

Related conditions